The stent-FP study investigates the impact of coverage of profound femoral artery (PFA) by bare metal stent deployed in proximal superficial femoral artery (SFA) lesions. 300 patients with femoral bifurcation lesions will be included and divided into 3 groups according to the location of proximal stent edge. The primary endpoint of the study is major adverse events and freedom from target lesion revascularization at 48 months. Secondary endpoints include primary patency of PFA and bare metal stent at 1,6, 12,24,36and 48 month, MAE and F -TLR at 1,6, 12,24,36 month.
Study Type
OBSERVATIONAL
Enrollment
300
The bare metal stent covers the deep femoral artery lower than 50%
The bare metal stent covers the deep femoral artery in 50-90%
The bare metal stent totally covers the deep femoral artery
Major adverse events and freedom from target lesion revascularization
Major adverse events and freedom from target lesion revascularization at 48 months
Time frame: post-interventional 48 months
primary patency of PFA and bare metal stent
primary patency of PFA and bare metal stent at 1,6, 12,24,36 and 48 month
Time frame: post-interventional 1,6, 12,24,36 and 48 month
MAE
Major adverse events at 1,6, 12,24,36 month
Time frame: post-interventional 1,6, 12,24,36 month
F -TLR
freedom from target lesion revascularization at 1,6, 12,24,36 month
Time frame: post-interventional 1,6, 12,24,36 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.